LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?

2024-05-30

$SATS LTD.(S58.SI)$ SATS Soars: Record Revenue and Profit Signal Takeoff for Aviation Industry Leader SATS Ltd. (SATS), the Singaporean aviation services giant, has reported a remarkable turnaround, posting a full-year profit of S$56.4 million for FY24. This stellar performance follows a year of losses and signifies a strong recovery fueled by the aviation sector's rebound and the successful integration of Worldwide Flight Services (WFS). Record-breaking Revenue: SATS' revenue tripled to a record S$5.1 billion in FY24, a clear reflection of the aviation industry's resurgence. This growth is further bolstered by the consolidation with WFS, a strategic move that is already delivering significant synergies. The integ

SPACE ROCKET

2024-05-29

What's also interesting and notable about $Novo-Nordisk A/S(NVO)$ is that it uses 100% renewable power in all their global production facilities, making them the only big pharma to do so. Having 0 environmental footprint, Novo Nordisk not just care about their patients, they care about the environment too. Lastly, Novo Nordisk is expected to beat analyst's estimates in first quarter 2024, driven by higher sales in Ozempic and Rybelsus. What's not to love about this stock?

SPACE ROCKET

2024-05-29

To give you context on how ridiculously costly some drugs are - $Novartis AG(NVS)$ Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status. Unlike these unethical big pharmas, $Novo-Nordisk A/S(NVO)$ aims to provide more affordable healthcare through advancements in R&D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2

SPACE ROCKET

2024-05-29

Founded in 1923 and headquartered just outside Denmark, $Novo-Nordisk A/S(NVO)$ is a global healthcare company aimed at defeating serious chronic diseases like diabetes. Having a market cap of DKK $310 trillion, Novo Nordisk is the world's 12th most valuable company, even bigger than the entire Danish economy. Unlike some big pharmas who priced drugs at exorbitant prices (making you wonder if they even care about making society better or are just interested in earning profits), Novo Nordisk is committed to helping societies defeat diabetes in a responsible and affordable manner.

koolgal

2024-05-29

🌟🌟🌟The Battle for Weight Loss Drug Supremacy is currently the domain of $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$. It is a huge USD 80 billion market globally. But soon there will be others trying to get a share of this lucrative weight loss market. I am optimistic on $Viking Therapeutics(VKTX)$ as it shows great promise due to its clinical trials. Already Viking Therapeutics Share price has jumped 257% year todate. I believe it can go higher once its drug is approved by the FDA.

Samlunch

2024-05-29

$Eli Lilly(LLY)$ $LLY June has been a consistently strong month for Eli Lily holders over the last 40 years as well: 65% win rate & average return of +2.54% 🟢

Samlunch

2024-05-29

$Eli Lilly(LLY)$ LLY quietly making higher highs and higher lows 📈 Ready for a breakout and another 20% move up 🚀 Get in, don't miss the boat! ⛴️

STLoke

2024-05-27

$Eli Lilly(LLY)$ $Novo-Nordisk A/S(NVO)$ Bullish Factors:Strong Performance: 1. Companies like Eli Lilly (LLY) and Novo Nordisk (NVO) have seen significant stock price increases (90% and 80% respectively) over the past two years, indicating strong market performance and investor confidence. 2. Market Demand: The increasing demand for effective weight-loss solutions provides a growing market for these companies. 3. Innovation: Hims' plan to offer weight-loss drugs at a significant discount compared to competitors like Wegovy indicates potential for disruption and market share gains. Considerations: 1. Valuation: High stock prices may reflect current market optimism, potentially limiting immediat

Iykyk

2024-05-23

What a good theme! Let's go go go

Samlunch

2024-05-23

$Pfizer(PFE)$ Looks like $PFE might be searching for a bottom here... Price reclaimed its 30-Week SMA, EPS back into profitability & its looking like YoY growth is around the corner. 💸

Samlunch

2024-05-21

$Starbucks(SBUX)$ Starbucks' sales have stalled in China, despite more and more stores being built

Samlunch

2024-05-20

$Hims & Hers Health Inc.(HIMS)$ Hims & Hers Health with a massive gap & go this morning after announcing addition of GLP-1 Injections to weight loss portfolio. $HIMS 🟢 +29.50%

Samlunch

2024-05-18

$Eli Lilly(LLY)$ Move over$NVIDIA Corp(NVDA)$ Take a look at LLY Bullish patterns keep repeating themselves Buy on breakout of the bull flag

KSR

2024-02-02

👍

Capital_Insights

2024-02-01

Healthcare Giants NVO & LLY Eye Trillion-Dollar Club

The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. $Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp

Healthcare Giants NVO & LLY Eye Trillion-Dollar Club

AndyAi

2023-10-28

Ehang buy tp 30 ?

gold

Ehang buy tp 30 ?

Sayaka

2023-10-28

How does an investor safeguard her portfolio and goals from high inflation? $Tesla Motors(TSLA)$ $NASDAQ-100 Index ETF(QQQ)$ $S&P500 ETF(SPY)$ $S&P 500(.SPX)$ Essentially, there are two broad ways. Outpacing inflation is about positioning your portfolio to grow bigger over a while and deliver returns that exceed the inflation rate. If your goal is to build a corpus for future spending and the goal is at least ten years away, then this strategy works. Hedge against inflation broadly focuses on protecting your near-term consumption from rising inflation. It is applicable especially if you are nea

Falafulu

2023-10-27

Many companies such as Pfizer and Amgen are developing weight loss drugs, as Barclays has predicted a $100 billion global market for obesity drugs by 2030. Females of ages 18-34 are the target customers of weight loss products. In a separate note, The sugar industry is an example of a weight-losing industry. Weight-gaining industries are industries whose raw materials are lighter but finished products are heavier and bulky. They tend to locate near markets.

Val FIU fisiga

2023-10-26

I try me so happy for this

MaverickWealthBuilder

2023-10-24

Why Shouldn't Investors Short Long-term Treasury?

Bill Ackman, who short on long-term US bonds, tweeted on October 23 that he had closed his position, for the current economic slowdown was more severe than the current data suggested, and the high yield of long-term US Treasury bonds was unsustainable. $iShares 20+ Year Treasury Bond ETF(TLT)$ Why are long-term US bond yields rising?US bond yields and bond prices are inversely proportional, and secondary market supply and demand can also affect yields through prices;Long-term US bond yields reflect expectations for future economic growth, while short-term yields are a direct reflection of market interest rates.As we have previously analyzed, the continuous rise in US bond yields is a comprehensive result of "economic growth" and "increased supply".

Why Shouldn't Investors Short Long-term Treasury?

Invest in Global Markets with Tiger Brokers!

Open App

{"data":{"themeId":"3ba18faeb8364f42b810a81bee429b4d","name":"LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?","description":"Eli Lilly expects fiscal year revenue to be between $45.4 billion and $46.6 billion, up from the previous forecast of $42.4 billion to $43.6 billion. Eli Lilly's stock surged 10% in pre-market trading.\nNovo Nordisk (NVO) stock tumbled Wednesday after the Danish drugmaker reported a rare sales miss.\n------------\nWhich weight loss drug company is a better buy?","image":"https://community-static.tradeup.com/news/96ede51e656d3728375f75b1fee3f8e4","type":0,"style":1,"follow":false,"createTime":1693893421238,"userCounts":21,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":3ba18faeb8364f42b810a81bee429b4d}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":true,"hasReward":true,"rewardScore":1000,"rewardValidDate":1723269419000,"rewardEnd":true,"symbols":[],"tweetCounts":109,"categoryId":"7a15628ce2174325bddc6229505e0d70","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"LLY Beats vs. NVO Misses:Which Weight Loss Drug Do You Favor?","tweetAmount":109,"imageIsDefault":false},"tab":"all","allList":[{"id":311394493468872,"gmtCreate":1717029704460,"gmtModify":1717033217634,"author":{"id":"4101948424484190","authorId":"4101948424484190","name":"Success88","avatar":"https://static.itradeup.com/news/4408e1a22d73e99adb53aa65dde8ad91","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4101948424484190","authorIdStr":"4101948424484190"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/S58.SI\">$SATS LTD.(S58.SI)$&nbsp;</a><v-v data-views=\"1\"></v-v> SATS Soars: Record Revenue and Profit Signal Takeoff for Aviation Industry Leader SATS Ltd. (SATS), the Singaporean aviation services giant, has reported a remarkable turnaround, posting a full-year profit of S$56.4 million for FY24. This stellar performance follows a year of losses and signifies a strong recovery fueled by the aviation sector's rebound and the successful integration of Worldwide Flight Services (WFS). Record-breaking Revenue: SATS' revenue tripled to a record S$5.1 billion in FY24, a clear reflection of the aviation industry's resurgence. This growth is further bolstered by the consolidation with WFS, a strategic move that is already delivering significant synergies. The integ","listText":"<a href=\"https://ttm.financial/S/S58.SI\">$SATS LTD.(S58.SI)$&nbsp;</a><v-v data-views=\"1\"></v-v> SATS Soars: Record Revenue and Profit Signal Takeoff for Aviation Industry Leader SATS Ltd. (SATS), the Singaporean aviation services giant, has reported a remarkable turnaround, posting a full-year profit of S$56.4 million for FY24. This stellar performance follows a year of losses and signifies a strong recovery fueled by the aviation sector's rebound and the successful integration of Worldwide Flight Services (WFS). Record-breaking Revenue: SATS' revenue tripled to a record S$5.1 billion in FY24, a clear reflection of the aviation industry's resurgence. This growth is further bolstered by the consolidation with WFS, a strategic move that is already delivering significant synergies. The integ","text":"$SATS LTD.(S58.SI)$ SATS Soars: Record Revenue and Profit Signal Takeoff for Aviation Industry Leader SATS Ltd. (SATS), the Singaporean aviation services giant, has reported a remarkable turnaround, posting a full-year profit of S$56.4 million for FY24. This stellar performance follows a year of losses and signifies a strong recovery fueled by the aviation sector's rebound and the successful integration of Worldwide Flight Services (WFS). Record-breaking Revenue: SATS' revenue tripled to a record S$5.1 billion in FY24, a clear reflection of the aviation industry's resurgence. This growth is further bolstered by the consolidation with WFS, a strategic move that is already delivering significant synergies. The integ","images":[{"img":"https://community-static.tradeup.com/news/000ad434366f2ddf5ee0a890cdab7ccc","width":"1179","height":"3758"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/311394493468872","isVote":1,"tweetType":1,"viewCount":2272,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},{"id":311295593541656,"gmtCreate":1717005505178,"gmtModify":1717005719219,"author":{"id":"4093561479903300","authorId":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/67ecba742430a57a532b690885139baa","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300","authorIdStr":"4093561479903300"},"themes":[],"htmlText":"What's also interesting and notable about&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; is that it uses 100% renewable power in all their global production facilities, making them the only big pharma to do so. Having 0 environmental footprint, Novo Nordisk not just care about their patients, they care about the environment too. Lastly, Novo Nordisk is expected to beat analyst's estimates in first quarter 2024, driven by higher sales in Ozempic and Rybelsus. What's not to love about this stock?","listText":"What's also interesting and notable about&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; is that it uses 100% renewable power in all their global production facilities, making them the only big pharma to do so. Having 0 environmental footprint, Novo Nordisk not just care about their patients, they care about the environment too. Lastly, Novo Nordisk is expected to beat analyst's estimates in first quarter 2024, driven by higher sales in Ozempic and Rybelsus. What's not to love about this stock?","text":"What's also interesting and notable about $Novo-Nordisk A/S(NVO)$ is that it uses 100% renewable power in all their global production facilities, making them the only big pharma to do so. Having 0 environmental footprint, Novo Nordisk not just care about their patients, they care about the environment too. Lastly, Novo Nordisk is expected to beat analyst's estimates in first quarter 2024, driven by higher sales in Ozempic and Rybelsus. What's not to love about this stock?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/311295593541656","isVote":1,"tweetType":1,"viewCount":573,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4132300740238052","authorId":"4132300740238052","name":"icycrystal","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"idStr":"4132300740238052","authorIdStr":"4132300740238052"},"content":"thanks for sharing","text":"thanks for sharing","html":"thanks for sharing"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311294838059160,"gmtCreate":1717005368306,"gmtModify":1717005700506,"author":{"id":"4093561479903300","authorId":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/67ecba742430a57a532b690885139baa","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300","authorIdStr":"4093561479903300"},"themes":[],"htmlText":"To give you context on how ridiculously costly some drugs are -&nbsp;<a href=\"https://ttm.financial/S/NVS\">$Novartis AG(NVS)$ </a> Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status. Unlike these unethical big pharmas,&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; aims to provide more affordable healthcare through advancements in R&amp;D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2","listText":"To give you context on how ridiculously costly some drugs are -&nbsp;<a href=\"https://ttm.financial/S/NVS\">$Novartis AG(NVS)$ </a> Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status. Unlike these unethical big pharmas,&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; aims to provide more affordable healthcare through advancements in R&amp;D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2","text":"To give you context on how ridiculously costly some drugs are - $Novartis AG(NVS)$ Zolgensma is a one-time-only gene therapy treatment for children (under two years) with spinal muscular atrophy (SMA). This drug cost an astronomical $2.1 million for a single treatment and favourable outcomes are not 100%. It's a drug meant to set apart the rich from the poor, and it is sad how children are denied treatment just because of their family's financial status. Unlike these unethical big pharmas, $Novo-Nordisk A/S(NVO)$ aims to provide more affordable healthcare through advancements in R&D, reducing price of its insulin by 75% (Mar 2023) and further cuts price of diabetes drug Ozempic (May 2","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/311294838059160","isVote":1,"tweetType":1,"viewCount":1066,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4132300740238052","authorId":"4132300740238052","name":"icycrystal","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"idStr":"4132300740238052","authorIdStr":"4132300740238052"},"content":"thanks for sharing","text":"thanks for sharing","html":"thanks for sharing"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311294088396960,"gmtCreate":1717005059547,"gmtModify":1717005635847,"author":{"id":"4093561479903300","authorId":"4093561479903300","name":"SPACE ROCKET","avatar":"https://community-static.tradeup.com/news/67ecba742430a57a532b690885139baa","crmLevel":9,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4093561479903300","authorIdStr":"4093561479903300"},"themes":[],"htmlText":"Founded in 1923 and headquartered just outside Denmark,&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a> is a global healthcare company aimed at defeating serious chronic diseases like diabetes. Having a market cap of DKK $310 trillion, Novo Nordisk is the world's 12th most valuable company, even bigger than the entire Danish economy. Unlike some big pharmas who priced drugs at exorbitant prices (making you wonder if they even care about making society better or are just interested in earning profits), Novo Nordisk is committed to helping societies defeat diabetes in a responsible and affordable manner.","listText":"Founded in 1923 and headquartered just outside Denmark,&nbsp;<a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a> is a global healthcare company aimed at defeating serious chronic diseases like diabetes. Having a market cap of DKK $310 trillion, Novo Nordisk is the world's 12th most valuable company, even bigger than the entire Danish economy. Unlike some big pharmas who priced drugs at exorbitant prices (making you wonder if they even care about making society better or are just interested in earning profits), Novo Nordisk is committed to helping societies defeat diabetes in a responsible and affordable manner.","text":"Founded in 1923 and headquartered just outside Denmark, $Novo-Nordisk A/S(NVO)$ is a global healthcare company aimed at defeating serious chronic diseases like diabetes. Having a market cap of DKK $310 trillion, Novo Nordisk is the world's 12th most valuable company, even bigger than the entire Danish economy. Unlike some big pharmas who priced drugs at exorbitant prices (making you wonder if they even care about making society better or are just interested in earning profits), Novo Nordisk is committed to helping societies defeat diabetes in a responsible and affordable manner.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/311294088396960","isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3569809505691000","authorId":"3569809505691000","name":"breAkdaWn","avatar":"https://community-static.tradeup.com/news/4c3676c14de9bfcd6f45bcf7ba4ddb6c","crmLevel":1,"crmLevelSwitch":0,"idStr":"3569809505691000","authorIdStr":"3569809505691000"},"content":"sadly it's true, eg. Pfizer, profits before care!!","text":"sadly it's true, eg. Pfizer, profits before care!!","html":"sadly it's true, eg. Pfizer, profits before care!!"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311164198055944,"gmtCreate":1716973346835,"gmtModify":1716973351481,"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"themes":[],"htmlText":"🌟🌟🌟The Battle for Weight Loss Drug Supremacy is currently the domain of <a href=\"https://ttm.financial/S/NVO\"> $Novo-Nordisk A/S(NVO)$ </a>and <a href=\"https://ttm.financial/S/LLY\"> $Eli Lilly(LLY)$</a>.&nbsp; It is a huge USD 80 billion market globally.&nbsp;&nbsp; But soon there will be others trying to get a share of this lucrative weight loss market.&nbsp; I am optimistic on <a href=\"https://ttm.financial/S/VKTX\"> $Viking Therapeutics(VKTX)$ </a>as it shows great promise due to its clinical trials.&nbsp;&nbsp;&nbsp; Already Viking Therapeutics Share price has jumped 257% year todate.&nbsp; I believe it can go higher once its drug is approved by the FDA.","listText":"🌟🌟🌟The Battle for Weight Loss Drug Supremacy is currently the domain of <a href=\"https://ttm.financial/S/NVO\"> $Novo-Nordisk A/S(NVO)$ </a>and <a href=\"https://ttm.financial/S/LLY\"> $Eli Lilly(LLY)$</a>.&nbsp; It is a huge USD 80 billion market globally.&nbsp;&nbsp; But soon there will be others trying to get a share of this lucrative weight loss market.&nbsp; I am optimistic on <a href=\"https://ttm.financial/S/VKTX\"> $Viking Therapeutics(VKTX)$ </a>as it shows great promise due to its clinical trials.&nbsp;&nbsp;&nbsp; Already Viking Therapeutics Share price has jumped 257% year todate.&nbsp; I believe it can go higher once its drug is approved by the FDA.","text":"🌟🌟🌟The Battle for Weight Loss Drug Supremacy is currently the domain of $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$. It is a huge USD 80 billion market globally. But soon there will be others trying to get a share of this lucrative weight loss market. I am optimistic on $Viking Therapeutics(VKTX)$ as it shows great promise due to its clinical trials. Already Viking Therapeutics Share price has jumped 257% year todate. I believe it can go higher once its drug is approved by the FDA.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":8,"repostSize":1,"link":"https://ttm.financial/post/311164198055944","isVote":1,"tweetType":1,"viewCount":897,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4132300740238052","authorId":"4132300740238052","name":"icycrystal","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0,"idStr":"4132300740238052","authorIdStr":"4132300740238052"},"content":"thanks for sharing","text":"thanks for sharing","html":"thanks for sharing"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":311121445544032,"gmtCreate":1716962909302,"gmtModify":1716962914225,"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3555293442593045","authorIdStr":"3555293442593045"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>&nbsp; $LLY June has been a consistently strong month for Eli Lily holders over the last 40 years as well: 65% win rate &amp; average return of +2.54% 🟢","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>&nbsp; $LLY June has been a consistently strong month for Eli Lily holders over the last 40 years as well: 65% win rate &amp; average return of +2.54% 🟢","text":"$Eli Lilly(LLY)$ $LLY June has been a consistently strong month for Eli Lily holders over the last 40 years as well: 65% win rate & average return of +2.54% 🟢","images":[{"img":"https://community-static.tradeup.com/news/3f44ff16dd0db10657c2eb7823ac0a39","width":"1125","height":"750"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/311121445544032","isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":311120786972792,"gmtCreate":1716962749570,"gmtModify":1716962754689,"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3555293442593045","authorIdStr":"3555293442593045"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>&nbsp; LLY quietly making higher highs and higher lows 📈&nbsp; Ready for a breakout and another 20% move up 🚀&nbsp; Get in, don't miss the boat! ⛴️&nbsp;","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>&nbsp; LLY quietly making higher highs and higher lows 📈&nbsp; Ready for a breakout and another 20% move up 🚀&nbsp; Get in, don't miss the boat! ⛴️&nbsp;","text":"$Eli Lilly(LLY)$ LLY quietly making higher highs and higher lows 📈 Ready for a breakout and another 20% move up 🚀 Get in, don't miss the boat! ⛴️","images":[{"img":"https://community-static.tradeup.com/news/22e25237463df2cf187eb8a64253fafa","width":"1125","height":"724"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/311120786972792","isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":310492549820488,"gmtCreate":1716813188336,"gmtModify":1716813195632,"author":{"id":"4088220260028080","authorId":"4088220260028080","name":"STLoke","avatar":"https://community-static.tradeup.com/news/e37fcc00ac6131a0820a34be1cd84d21","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4088220260028080","authorIdStr":"4088220260028080"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$ </a><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; Bullish Factors:Strong Performance:&nbsp; 1. Companies like Eli Lilly (LLY) and Novo Nordisk (NVO) have seen significant stock price increases (90% and 80% respectively) over the past two years, indicating strong market performance and investor confidence. 2. Market Demand: The increasing demand for effective weight-loss solutions provides a growing market for these companies. 3. Innovation: Hims' plan to offer weight-loss drugs at a significant discount compared to competitors like Wegovy indicates potential for disruption and market share gains. Considerations: 1. Valuation: High stock prices may reflect current market optimism, potentially limiting immediat","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$ </a><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$ </a>&nbsp; Bullish Factors:Strong Performance:&nbsp; 1. Companies like Eli Lilly (LLY) and Novo Nordisk (NVO) have seen significant stock price increases (90% and 80% respectively) over the past two years, indicating strong market performance and investor confidence. 2. Market Demand: The increasing demand for effective weight-loss solutions provides a growing market for these companies. 3. Innovation: Hims' plan to offer weight-loss drugs at a significant discount compared to competitors like Wegovy indicates potential for disruption and market share gains. Considerations: 1. Valuation: High stock prices may reflect current market optimism, potentially limiting immediat","text":"$Eli Lilly(LLY)$ $Novo-Nordisk A/S(NVO)$ Bullish Factors:Strong Performance: 1. Companies like Eli Lilly (LLY) and Novo Nordisk (NVO) have seen significant stock price increases (90% and 80% respectively) over the past two years, indicating strong market performance and investor confidence. 2. Market Demand: The increasing demand for effective weight-loss solutions provides a growing market for these companies. 3. Innovation: Hims' plan to offer weight-loss drugs at a significant discount compared to competitors like Wegovy indicates potential for disruption and market share gains. Considerations: 1. Valuation: High stock prices may reflect current market optimism, potentially limiting immediat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/310492549820488","isVote":1,"tweetType":1,"viewCount":1359,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":308904322314336,"gmtCreate":1716443887151,"gmtModify":1716443890543,"author":{"id":"3561094934768918","authorId":"3561094934768918","name":"Iykyk","avatar":"https://community-static.tradeup.com/news/4330127ff99e15a7dc358c141514b8c3","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561094934768918","authorIdStr":"3561094934768918"},"themes":[],"htmlText":"What a good theme! Let's go go go","listText":"What a good theme! Let's go go go","text":"What a good theme! Let's go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/308904322314336","isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":308818106847352,"gmtCreate":1716422843507,"gmtModify":1716422848756,"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3555293442593045","authorIdStr":"3555293442593045"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/PFE\">$Pfizer(PFE)$</a>&nbsp; Looks like $PFE might be searching for a bottom here... Price reclaimed its 30-Week SMA, EPS back into profitability &amp; its looking like YoY growth is around the corner. 💸","listText":"<a href=\"https://ttm.financial/S/PFE\">$Pfizer(PFE)$</a>&nbsp; Looks like $PFE might be searching for a bottom here... Price reclaimed its 30-Week SMA, EPS back into profitability &amp; its looking like YoY growth is around the corner. 💸","text":"$Pfizer(PFE)$ Looks like $PFE might be searching for a bottom here... Price reclaimed its 30-Week SMA, EPS back into profitability & its looking like YoY growth is around the corner. 💸","images":[{"img":"https://community-static.tradeup.com/news/813e57986516c7f0ce99c697ab06d363","width":"1125","height":"724"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/308818106847352","isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":308322208292952,"gmtCreate":1716295816975,"gmtModify":1716295821601,"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3555293442593045","authorIdStr":"3555293442593045"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/SBUX\">$Starbucks(SBUX)$</a>&nbsp; Starbucks' sales have stalled in China, despite more and more stores being built","listText":"<a href=\"https://ttm.financial/S/SBUX\">$Starbucks(SBUX)$</a>&nbsp; Starbucks' sales have stalled in China, despite more and more stores being built","text":"$Starbucks(SBUX)$ Starbucks' sales have stalled in China, despite more and more stores being built","images":[{"img":"https://community-static.tradeup.com/news/ac87833f613265826369e4db160a0242","width":"1125","height":"1125"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/308322208292952","isVote":1,"tweetType":1,"viewCount":134,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":307994967666880,"gmtCreate":1716215926082,"gmtModify":1716274016704,"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3555293442593045","authorIdStr":"3555293442593045"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a>&nbsp; Hims &amp; Hers Health with a massive gap &amp; go this morning after announcing addition of GLP-1 Injections to weight loss portfolio. $HIMS 🟢 +29.50%","listText":"<a href=\"https://ttm.financial/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a>&nbsp; Hims &amp; Hers Health with a massive gap &amp; go this morning after announcing addition of GLP-1 Injections to weight loss portfolio. $HIMS 🟢 +29.50%","text":"$Hims & Hers Health Inc.(HIMS)$ Hims & Hers Health with a massive gap & go this morning after announcing addition of GLP-1 Injections to weight loss portfolio. $HIMS 🟢 +29.50%","images":[{"img":"https://community-static.tradeup.com/news/541d856075963dcbca4a536f99ea65d7","width":"1128","height":"726"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":2,"link":"https://ttm.financial/post/307994967666880","isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":307041365729576,"gmtCreate":1715996521588,"gmtModify":1716274200022,"author":{"id":"3555293442593045","authorId":"3555293442593045","name":"Samlunch","avatar":"https://static.tigerbbs.com/17478579b111537e74aea4d338e8aef5","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3555293442593045","authorIdStr":"3555293442593045"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>&nbsp; Move over<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a>&nbsp; Take a look at LLY Bullish patterns keep repeating themselves Buy on breakout of the bull flag","listText":"<a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>&nbsp; Move over<a href=\"https://ttm.financial/S/NVDA\">$NVIDIA Corp(NVDA)$&nbsp;</a>&nbsp; Take a look at LLY Bullish patterns keep repeating themselves Buy on breakout of the bull flag","text":"$Eli Lilly(LLY)$ Move over$NVIDIA Corp(NVDA)$ Take a look at LLY Bullish patterns keep repeating themselves Buy on breakout of the bull flag","images":[{"img":"https://community-static.tradeup.com/news/e632319c1ce7f3e8a9bf78823de87c16","width":"1179","height":"2103"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/307041365729576","isVote":1,"tweetType":1,"viewCount":547,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":269602863497400,"gmtCreate":1706837999020,"gmtModify":1706838002738,"author":{"id":"4121076730674632","authorId":"4121076730674632","name":"KSR","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4121076730674632","authorIdStr":"4121076730674632"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/269602863497400","isVote":1,"tweetType":1,"viewCount":187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":269377699418120,"gmtCreate":1706790651828,"gmtModify":1707122633500,"author":{"id":"3527667668165440","authorId":"3527667668165440","name":"Capital_Insights","avatar":"https://static.tigerbbs.com/cfdc66fff48bb2b9e2d328ac5eb33100","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667668165440","authorIdStr":"3527667668165440"},"themes":[],"title":"Healthcare Giants NVO & LLY Eye Trillion-Dollar Club","htmlText":"The Government Pension Fund Global predicts that <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","listText":"The Government Pension Fund Global predicts that <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a> and <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a> could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$</a>'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$</a>’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","text":"The Government Pension Fund Global predicts that $Novo-Nordisk A/S(NVO)$ and $Eli Lilly(LLY)$ could be the first healthcare companies to reach trillion-dollar club, benefiting from the rising demand for diabetes and weight-loss drugs. With less than 1% of overweight individuals currently receiving treatment, the potential market for these drugs remains vast. $Novo-Nordisk A/S(NVO)$'s strong earnings, driven by the success of its drug Wegovy, pushed its market value to $511.29 bln.While $Eli Lilly(LLY)$’s market capitalization stands at around $612 bln. The Government Pension Fund Global holds significant stakes in both comp","images":[{"img":"https://community-static.tradeup.com/news/5d7a758ba9b42553dfa4c4a186caf25e","width":"1540","height":"705"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":472,"commentSize":2,"repostSize":72,"link":"https://ttm.financial/post/269377699418120","isVote":1,"tweetType":1,"viewCount":3377,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3479274781763777","authorId":"3479274781763777","name":"tothehill","avatar":"https://static.tigerbbs.com/d63237e21ae39bc54951c8ab6ec41ee9","crmLevel":1,"crmLevelSwitch":0,"idStr":"3479274781763777","authorIdStr":"3479274781763777"},"content":"Hilarious market potential! 😂 Agree! 🙌","text":"Hilarious market potential! 😂 Agree! 🙌","html":"Hilarious market potential! 😂 Agree! 🙌"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":235521047994592,"gmtCreate":1698533068147,"gmtModify":1698533073320,"author":{"id":"3549659726191917","authorId":"3549659726191917","name":"AndyAi","avatar":"https://static.tigerbbs.com/81c12ecb4451acc5f55df3fef66d9790","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3549659726191917","authorIdStr":"3549659726191917"},"themes":[],"title":"Ehang buy tp 30 ? ","htmlText":"gold&nbsp;","listText":"gold&nbsp;","text":"gold","images":[],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/235521047994592","isVote":1,"tweetType":1,"viewCount":1690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":235242746994912,"gmtCreate":1698465123568,"gmtModify":1698465131497,"author":{"id":"3575357760164357","authorId":"3575357760164357","name":"Sayaka","avatar":"https://static.tigerbbs.com/b9ba234a6653e4f0c99910e770326f38","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575357760164357","authorIdStr":"3575357760164357"},"themes":[],"htmlText":"How does an investor safeguard her portfolio and goals from high inflation? <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><a href=\"https://ttm.financial/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$&nbsp;</a><a href=\"https://ttm.financial/S/SPY\">$S&amp;P500 ETF(SPY)$&nbsp;</a><a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$&nbsp;</a> Essentially, there are two broad ways. Outpacing inflation is about positioning your portfolio to grow bigger over a while and deliver returns that exceed the inflation rate. If your goal is to build a corpus for future spending and the goal is at least ten years away, then this strategy works. Hedge against inflation broadly focuses on protecting your near-term consumption from rising inflation. It is applicable especially if you are nea","listText":"How does an investor safeguard her portfolio and goals from high inflation? <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$&nbsp;</a><a href=\"https://ttm.financial/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$&nbsp;</a><a href=\"https://ttm.financial/S/SPY\">$S&amp;P500 ETF(SPY)$&nbsp;</a><a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$&nbsp;</a> Essentially, there are two broad ways. Outpacing inflation is about positioning your portfolio to grow bigger over a while and deliver returns that exceed the inflation rate. If your goal is to build a corpus for future spending and the goal is at least ten years away, then this strategy works. Hedge against inflation broadly focuses on protecting your near-term consumption from rising inflation. It is applicable especially if you are nea","text":"How does an investor safeguard her portfolio and goals from high inflation? $Tesla Motors(TSLA)$ $NASDAQ-100 Index ETF(QQQ)$ $S&P500 ETF(SPY)$ $S&P 500(.SPX)$ Essentially, there are two broad ways. Outpacing inflation is about positioning your portfolio to grow bigger over a while and deliver returns that exceed the inflation rate. If your goal is to build a corpus for future spending and the goal is at least ten years away, then this strategy works. Hedge against inflation broadly focuses on protecting your near-term consumption from rising inflation. It is applicable especially if you are nea","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/235242746994912","isVote":1,"tweetType":1,"viewCount":1470,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":234937697144840,"gmtCreate":1698379333979,"gmtModify":1698379338066,"author":{"id":"3554966833368904","authorId":"3554966833368904","name":"Falafulu","avatar":"https://static.tigerbbs.com/57de22e9bf76a9f36da485155977e123","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554966833368904","authorIdStr":"3554966833368904"},"themes":[],"htmlText":"Many companies such as Pfizer and Amgen are developing weight loss drugs, as Barclays has predicted a $100 billion global market for obesity drugs by 2030. Females of ages 18-34 are the target customers of weight loss products. In a separate note,&nbsp; The sugar industry is an example of a weight-losing industry. Weight-gaining industries are industries whose raw materials are lighter but finished products are heavier and bulky. They tend to locate near markets.","listText":"Many companies such as Pfizer and Amgen are developing weight loss drugs, as Barclays has predicted a $100 billion global market for obesity drugs by 2030. Females of ages 18-34 are the target customers of weight loss products. In a separate note,&nbsp; The sugar industry is an example of a weight-losing industry. Weight-gaining industries are industries whose raw materials are lighter but finished products are heavier and bulky. They tend to locate near markets.","text":"Many companies such as Pfizer and Amgen are developing weight loss drugs, as Barclays has predicted a $100 billion global market for obesity drugs by 2030. Females of ages 18-34 are the target customers of weight loss products. In a separate note, The sugar industry is an example of a weight-losing industry. Weight-gaining industries are industries whose raw materials are lighter but finished products are heavier and bulky. They tend to locate near markets.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/234937697144840","isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":234822059761880,"gmtCreate":1698351203079,"gmtModify":1698351207380,"author":{"id":"4160169019033422","authorId":"4160169019033422","name":"Val FIU fisiga","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4160169019033422","authorIdStr":"4160169019033422"},"themes":[],"htmlText":"I try me so happy for this","listText":"I try me so happy for this","text":"I try me so happy for this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/234822059761880","isVote":1,"tweetType":1,"viewCount":1149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":233898895949840,"gmtCreate":1698130311574,"gmtModify":1698130465785,"author":{"id":"4102740236684050","authorId":"4102740236684050","name":"MaverickWealthBuilder","avatar":"https://community-static.tradeup.com/news/bbf0f514b8e5abb92266789b89f6e1e6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4102740236684050","authorIdStr":"4102740236684050"},"themes":[],"title":"Why Shouldn't Investors Short Long-term Treasury?","htmlText":"Bill Ackman, who short on long-term US bonds, tweeted on October 23 that he had closed his position, for the current economic slowdown was more severe than the current data suggested, and the high yield of long-term US Treasury bonds was unsustainable. <a href=\"https://ttm.financial/S/TLT\">$iShares 20+ Year Treasury Bond ETF(TLT)$</a> Why are long-term US bond yields rising?US bond yields and bond prices are inversely proportional, and secondary market supply and demand can also affect yields through prices;Long-term US bond yields reflect expectations for future economic growth, while short-term yields are a direct reflection of market interest rates.As we have previously analyzed, the continuous rise in US bond yields is a comprehensive result of \"economic growth\" and \"increased supply\".","listText":"Bill Ackman, who short on long-term US bonds, tweeted on October 23 that he had closed his position, for the current economic slowdown was more severe than the current data suggested, and the high yield of long-term US Treasury bonds was unsustainable. <a href=\"https://ttm.financial/S/TLT\">$iShares 20+ Year Treasury Bond ETF(TLT)$</a> Why are long-term US bond yields rising?US bond yields and bond prices are inversely proportional, and secondary market supply and demand can also affect yields through prices;Long-term US bond yields reflect expectations for future economic growth, while short-term yields are a direct reflection of market interest rates.As we have previously analyzed, the continuous rise in US bond yields is a comprehensive result of \"economic growth\" and \"increased supply\".","text":"Bill Ackman, who short on long-term US bonds, tweeted on October 23 that he had closed his position, for the current economic slowdown was more severe than the current data suggested, and the high yield of long-term US Treasury bonds was unsustainable. $iShares 20+ Year Treasury Bond ETF(TLT)$ Why are long-term US bond yields rising?US bond yields and bond prices are inversely proportional, and secondary market supply and demand can also affect yields through prices;Long-term US bond yields reflect expectations for future economic growth, while short-term yields are a direct reflection of market interest rates.As we have previously analyzed, the continuous rise in US bond yields is a comprehensive result of \"economic growth\" and \"increased supply\".","images":[{"img":"https://static.tigerbbs.com/2bfcccbd37f96ef2aced5dd7a8eeb0a0","width":"788","height":"563"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":220,"commentSize":6,"repostSize":20,"link":"https://ttm.financial/post/233898895949840","isVote":1,"tweetType":1,"viewCount":2837,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000672","authorId":"9000000000000672","name":"cheeryx","avatar":"https://static.tigerbbs.com/3eb335d4670b62d2f6f58595a4ebf23b","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000672","authorIdStr":"9000000000000672"},"content":"I hate to throw a wet blanket on top of an up day, but we’re likely going to see a Q3 real GDP print of around 5% Friday and the bond market is not going to like it.","text":"I hate to throw a wet blanket on top of an up day, but we’re likely going to see a Q3 real GDP print of around 5% Friday and the bond market is not going to like it.","html":"I hate to throw a wet blanket on top of an up day, but we’re likely going to see a Q3 real GDP print of around 5% Friday and the bond market is not going to like it."}],"imageCount":2,"langContent":"EN","totalScore":0}],"essenList":[]}